Form D · Biotechnology
Cirius Therapeutics, Inc.
Grand Rapids, MI · CIK 0001702956
Offering snapshot reported Oct 8, 2025 · SEC filing
- Reported sold
- $800K Offering amount: $1.2M
- Investors reported
- 22 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 7, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 8, 2025 | Initial | $800,000 | No comparison | 22 | SEC filing |
| Oct 15, 2024 | Initial | $1,000,000 | No comparison | 22 | SEC filing |
| Aug 20, 2024 | Initial | $1,300,000 | No comparison | 24 | SEC filing |
| May 14, 2019 | Initial | $7,499,972 | No comparison | 29 | SEC filing |
| Aug 30, 2018 | Initial | $9,000,000 | No comparison | 30 | SEC filing |
| Apr 10, 2017 | Initial | $30,000,003 | No comparison | 21 | SEC filing |
Offering details
- Securities
- Debt, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-560203
Source: Form D, filed Oct 8, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Robert Baltera | Director, Executive |
| Robert A Beardsley | Executive |
| Baltera Bob | Director, Executive |
| Jerry Callahan | Executive |
| Howard Dittrich | Executive |
| Daniel Estes | Director |
| Daniel Estes, Ph.D. | Director |
| Brian Farmer | Executive |
| Dennis Fenton, Ph.D. | Director |
| Michael Jandernoa | Director |
| Nilesh Kumar | Director |
| Nilesh Kumar, Ph.D. | Director |
| Mark Olesnavage | Executive |
| Elaine Sun | Director |
| David Van Andel | Director |
| Robert Zerbe | Director |
| Robert Zerbe, M.D. | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
3133 Orchard Vista Dr. Sw
Grand Rapids, MI, 49546
Grand Rapids, MI, 49546